Home / Inspections / 1216782

FDA Inspection 1216782 — TriRx Huntsville Pharmaceutical Services, LLC

TriRx Huntsville Pharmaceutical Services, LLC — FEI 3003197096

The FDA completed an inspection of TriRx Huntsville Pharmaceutical Services, LLC on August 11, 2023 in Huntsville, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 11, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Huntsville, AL (United States)

Facility

Other inspections at this facility

  • 1166895 (VAI Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 978625 (NAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 908381 (VAI Fri Dec 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891076 (VAI Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888276 (NAI Thu Jul 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources